Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Functional genetic variation in aminopeptidase A (ENPEP): lack of clear association with focal and segmental glomerulosclerosis (FSGS).

Tonna S, Dandapani SV, Uscinski A, Appel GB, Schlöndorff JS, Zhang K, Denker BM, Pollak MR.

Gene. 2008 Feb 29;410(1):44-52. doi: 10.1016/j.gene.2007.11.014. Epub 2007 Dec 3.

2.

NPHS2 variation in focal and segmental glomerulosclerosis.

Tonna SJ, Needham A, Polu K, Uscinski A, Appel GB, Falk RJ, Katz A, Al-Waheeb S, Kaplan BS, Jerums G, Savige J, Harmon J, Zhang K, Curhan GC, Pollak MR.

BMC Nephrol. 2008 Sep 29;9:13. doi: 10.1186/1471-2369-9-13.

3.

Expression and effect of inhibition of aminopeptidase-A during nephrogenesis.

Dijkman HB, Assmann KJ, Steenbergen EJ, Wetzels JF.

J Histochem Cytochem. 2006 Feb;54(2):253-62. Epub 2005 Nov 14.

PMID:
16286663
4.

Focal and segmental glomerulosclerosis in mice with podocyte-specific expression of mutant alpha-actinin-4.

Michaud JL, Lemieux LI, Dubé M, Vanderhyden BC, Robertson SJ, Kennedy CR.

J Am Soc Nephrol. 2003 May;14(5):1200-11.

5.

HIV-associated nephropathy: experimental models.

Avila-Casado C, Fortoul TI, Chugh SS.

Contrib Nephrol. 2011;169:270-85. doi: 10.1159/000320212. Epub 2011 Jan 20.

PMID:
21252526
6.

Variants in the Wilms' tumor gene are associated with focal segmental glomerulosclerosis in the African American population.

Orloff MS, Iyengar SK, Winkler CA, Goddard KA, Dart RA, Ahuja TS, Mokrzycki M, Briggs WA, Korbet SM, Kimmel PL, Simon EE, Trachtman H, Vlahov D, Michel DM, Berns JS, Smith MC, Schelling JR, Sedor JR, Kopp JB.

Physiol Genomics. 2005 Apr 14;21(2):212-21. Epub 2005 Feb 1.

7.

Mutational and Biological Analysis of alpha-actinin-4 in focal segmental glomerulosclerosis.

Weins A, Kenlan P, Herbert S, Le TC, Villegas I, Kaplan BS, Appel GB, Pollak MR.

J Am Soc Nephrol. 2005 Dec;16(12):3694-701. Epub 2005 Oct 26.

8.

Antibody-induced albuminuria and accelerated focal glomerulosclerosis in the Thy-1.1 transgenic mouse.

Assmann KJ, van Son JP, Dïjkman HB, Mentzel S, Wetzels JF.

Kidney Int. 2002 Jul;62(1):116-26.

9.

Mechanisms of disease: focal segmental glomerulosclerosis.

Meyrier A.

Nat Clin Pract Nephrol. 2005 Nov;1(1):44-54. Review.

PMID:
16932363
10.

Aminopeptidase A, which generates one of the main effector peptides of the brain renin-angiotensin system, angiotensin III, has a key role in central control of arterial blood pressure.

Reaux A, Iturrioz X, Vazeux G, Fournie-Zaluski MC, David C, Roques BP, Corvol P, Llorens-Cortes C.

Biochem Soc Trans. 2000;28(4):435-40. Review.

PMID:
10961935
11.
12.

Angiotensin converting enzyme inhibition prevents development of collapsing focal segmental glomerulosclerosis in Thy-1.1 transgenic mice.

Smeets B, Steenbergen ML, Dijkman HB, Verrijp KN, te Loeke NA, Aten J, Steenbergen EJ, Wetzels JF.

Nephrol Dial Transplant. 2006 Nov;21(11):3087-97. Epub 2006 Sep 12.

13.

Focal segmental glomerulosclerosis is associated with a PDSS2 haplotype and, independently, with a decreased content of coenzyme Q10.

Gasser DL, Winkler CA, Peng M, An P, McKenzie LM, Kirk GD, Shi Y, Xie LX, Marbois BN, Clarke CF, Kopp JB.

Am J Physiol Renal Physiol. 2013 Oct 15;305(8):F1228-38. doi: 10.1152/ajprenal.00143.2013. Epub 2013 Aug 7.

14.

Pathobiology of focal segmental glomerulosclerosis: new developments.

D'Agati VD.

Curr Opin Nephrol Hypertens. 2012 May;21(3):243-50. doi: 10.1097/MNH.0b013e32835200df. Review.

PMID:
22357339
15.

Angiotensin-converting enzyme gene polymorphism and the progression rate of focal segmental glomerulosclerosis in Iranian children.

Gheissari A, Salehi M, Dastjerdi SB, Jahangiri M, Hooman N, Otookesh H, Merikhipour A, Ajir A, Foroughmand A, Khatami S, Shahidi S, Atapour A, Seirafian S, Naeini AE.

Nephrology (Carlton). 2008 Dec;13(8):708-11. doi: 10.1111/j.1440-1797.2008.00990.x. Epub 2008 Dec 5.

PMID:
19076285
16.

The association between angiotensin-converting enzyme insertion/deletion gene variant and risk of focal segmental glomerulosclerosis: a systematic review and meta-analysis.

Zhou TB, Qin YH, Su LN, Lei FY, Huang WF, Zhao YJ, Pang YS, Yang KP.

J Renin Angiotensin Aldosterone Syst. 2011 Dec;12(4):624-33. doi: 10.1177/1470320311410584. Epub 2011 Jun 7. Review.

PMID:
21652690
17.

Ubiquitin C-terminal hydrolase L1 deletion ameliorates glomerular injury in mice with ACTN4-associated focal segmental glomerulosclerosis.

Read NC, Gutsol A, Holterman CE, Carter A, Coulombe J, Gray DA, Kennedy CR.

Biochim Biophys Acta. 2014 Jul;1842(7):1028-40. doi: 10.1016/j.bbadis.2014.03.009. Epub 2014 Mar 22.

18.

Bigenic mouse models of focal segmental glomerulosclerosis involving pairwise interaction of CD2AP, Fyn, and synaptopodin.

Huber TB, Kwoh C, Wu H, Asanuma K, Gödel M, Hartleben B, Blumer KJ, Miner JH, Mundel P, Shaw AS.

J Clin Invest. 2006 May;116(5):1337-45. Epub 2006 Apr 20.

19.

Effects of the genetic polymorphisms of the renin-angiotensin system on focal segmental glomerulosclerosis.

Luther Y, Bantis C, Ivens K, Fehsel K, Kolb-Bachhofen V, Heering P.

Kidney Blood Press Res. 2003;26(5-6):333-7.

20.

A role for genetic susceptibility in sporadic focal segmental glomerulosclerosis.

Yu H, Artomov M, Brähler S, Stander MC, Shamsan G, Sampson MG, White JM, Kretzler M, Miner JH, Jain S, Winkler CA, Mitra RD, Kopp JB, Daly MJ, Shaw AS.

J Clin Invest. 2016 Mar 1;126(3):1067-78. doi: 10.1172/JCI82592. Epub 2016 Feb 22. Erratum in: J Clin Invest. 2016 Apr 1;126(4):1603.

Items per page

Supplemental Content

Write to the Help Desk